在口腔状细胞癌中潜在的前瘤细胞因子:IL37
Ying Yan1,2,3, Jun Li1,2,3, Yungang He1,2,3
1Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Journal of cellular and molecular medicine
|November 5, 2024
概括
干白素37 (IL37) 在口腔状细胞癌 (OSCC) 中升高,由低氧驱动. 通过改变巨细胞功能,IL37促进瘤生长,这表明它是OSCC的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 口腔状细胞癌 (OSCC) 表现出炎症和免疫抑制.
- 干白素37 (IL37) 是一种细胞因子,在瘤免疫中具有复杂的作用.
- 了解OSCC中的IL37调节和功能对于治疗至关重要.
研究的目的:
- 在OSCC中研究IL37的调节机制.
- 阐明IL37在OSCC进展和瘤微环境中的作用.
- 确定IL37作为OSCC的潜在治疗点.
主要方法:
- 在OSCC组织中量化IL37,CD86和CD206.
- 在体外研究使用缺氧,MCC950和siRNA-Gasdermin D (GSDMD) 来研究IL37的产生和释放.
- 在体内动物模型中评估IL37在OSCC生长中的作用.
主要成果:
- 在OSCC组织中,IL37水平明显高于正常口腔粘膜.
- 缺氧诱导IL37表达和释放通过NLRP3炎症酶激活和GSDMD.
- 升高的IL37与M2巨细胞极化相关,与M1巨细胞负相关.
- IL37通过增强M2极化和瘤细胞增殖,促进OSCC的进展.
结论:
- 缺氧是OSCC中IL37产生和释放的关键调节者.
- IL37通过巨细胞极化和瘤细胞增殖促进OSCC的进展.
- IL37代表了口腔状细胞癌的一个有前途的治疗标.
相关概念视频
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484


